A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis

0.50 hr(s) | CME

Specialty: Amyotrophic Lateral Sclerosis

Therapeutic Area(s): Neurology

Release Date: June 8, 2021

Expiration Date: June 7, 2022

Location: Internet Activity Enduring

In this activity, an expert in neurology discusses the use of antisense oligonucleotide therapies in patients with amyotrophic lateral sclerosis (ALS).

Access this activity
Share via
Copy link
Powered by Social Snap